Posted On: 01/08/2015 8:29:05 PM
Post# of 30066

Re: biotechexpert #14582
I really would like to uplist from strength from a much higher price. However, you bring up a good point. We know we are going to have some strong catalysts, so the 'strength' is there from that perspective. I would much prefer exposure of those catalysts on the Nasdaq regardless of how big a RS would have to be. Institutions would be able to play the game and support the share price.

